Interactions between surface‐bound actin and complement, platelets, and neutrophils
Source abstract
Abstract
Abstract Actin exists as globular (G) monomers or polymeric filaments (F) in the cytoplasm of eukaryotic cells, mediating cell morphologic changes and motility. Large amounts of this protein may be released out to the extracellular compartment during tissue injury, but little is known about its role in biomaterial‐related inflammation. We immobilized actin to methylated glass, methylated and aminated silicon, and gold model surfaces and studied the subsequent blood serum deposition and complement activation, generation of reactive oxygen species (ROS), and adhesion and aggregation of neutrophils and platelets. Null ellipsometry showed that approximately one monolayer of G‐actin can be immobilized onto the model surfaces and that actin in buffer polymerized on top of this by the addition of K+ and Mg2+ ions to form a thicker layer of firmly bound F‐actin. After serum incubation, F‐actin bound low amounts of anti‐complement factor 1q (anti‐C1q). Cell responses upon contact with actin‐coated surfaces were analyzed by luminol‐amplified chemiluminescence, lumi‐aggregometry, and fluorescence microscopy. It was shown that surface‐triggered aggregation, spreading, and generation of ROS are down‐regulated and comparable to the response by adsorbed albumin. However, F‐actin on gold surfaces recruited platelets in a C1q‐dependent manner. We conclude that in vitro adsorbed actin is a weak complement, platelet, and neutrophil activator, but that F‐actin associates with both C1q and platelets. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 66A: 162–175, 2003
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Cell Adhesion Molecules Research · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (60)
Show source-provided references
1. 10.1002/jbm.82003010610.1002/jbm.820030106 ↗
2. 10.1093/ajcp/103.4.46610.1093/ajcp/103.4.466 ↗
3. Cooper NR · 1999 · 281
4. 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I ↗
5. 10.1111/j.1749-6632.1987.tb33051.x10.1111/j.1749-6632.1987.tb33051.x ↗
6. 10.1016/0142-9612(88)90066-X10.1016/0142-9612(88)90066-X ↗
7. 10.1038/ki.1989.18810.1038/ki.1989.188 ↗
8. 10.1016/0142-9612(96)84675-810.1016/0142-9612(96)84675-8 ↗
9. 10.1111/j.1523-1755.1998.00836.x10.1111/j.1523-1755.1998.00836.x ↗
10. 10.1016/S0142-9612(01)00203-410.1016/S0142-9612(01)00203-4 ↗
11. Stossel TP · 1999 · 663
12. 10.1164/ajrccm/138.2.42910.1164/ajrccm/138.2.429 ↗
13. Circulating actin–gelsolin complexes following oleic acid‐induced lung injury
14. 10.1016/0955-0674(95)80052-210.1016/0955-0674(95)80052-2 ↗
15. 10.1083/jcb.118.6.142110.1083/jcb.118.6.1421 ↗
16. 10.1073/pnas.90.8.328010.1073/pnas.90.8.3280 ↗
17. Actin dynamics in human neutrophils during adhesion and phagocytosis is controlled by changes in intracellular free calcium
18. Capacity of human serum to depolymerize actin filaments10.1182/blood.V70.2.524.524 ↗
19. 10.1007/s00134000083710.1007/s001340000837 ↗
20. 10.1016/S0006-3495(00)76558-110.1016/S0006-3495(00)76558-1 ↗
21. 10.1016/S0006-3495(99)77317-010.1016/S0006-3495(99)77317-0 ↗
22. 10.1164/ajrccm.162.1.980608810.1164/ajrccm.162.1.9806088 ↗
23. 10.1016/0960-0760(95)00104-810.1016/0960-0760(95)00104-8 ↗
24. 10.1016/0006-291X(82)92142-810.1016/0006-291X(82)92142-8 ↗
25. 10.1016/0161-5890(79)90086-510.1016/0161-5890(79)90086-5 ↗
26. Effects of actin filaments on fibrin clot structure and lysis10.1182/blood.V80.4.928.928 ↗
27. Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots
28. 10.1006/bbrc.1996.588110.1006/bbrc.1996.5881 ↗
29. 10.1182/blood.V93.5.146410.1182/blood.V93.5.1464 ↗
30. 10.1016/S0049-3848(01)00341-310.1016/S0049-3848(01)00341-3 ↗
31. 10.1182/blood.V82.12.3648.364810.1182/blood.V82.12.3648.3648 ↗
32. Loos M · 1998 · 1
33. Cleaning solutions based on hydrogen peroxide for use in silicon semiconductor technology
34. 10.1149/1.212916210.1149/1.2129162 ↗
35. Hermansson GT · 1992
36. 10.1007/BF0291642110.1007/BF02916421 ↗
37. 10.1016/0021-9797(87)90260-810.1016/0021-9797(87)90260-8 ↗
38. McCrackinFL.A Fortran program for analysis of ellipsometer measurements. In: NBS Technical Note 479;1969.10.6028/NBS.TN.479 ↗
39. 10.1002/bip.1978.36017071110.1002/bip.1978.360170711 ↗
40. 10.1163/156856297X0056010.1163/156856297X00560 ↗
41. 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q ↗
42. 10.1038/204793a010.1038/204793a0 ↗
43. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g
44. 10.1016/0022-1759(80)90036-810.1016/0022-1759(80)90036-8 ↗
45. Platelets amplify chemotactic peptide‐induced changes in F‐actin and calcium in human neutrophils
46. Chemiluminescence as a means of following the function of phagocytic cells
47. 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D ↗
48. 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T ↗
49. 10.1016/S0142-9612(02)00543-410.1016/S0142-9612(02)00543-4 ↗
50. 10.1016/0039-6028(85)90290-010.1016/0039-6028(85)90290-0 ↗
51. 10.1002/jlb.60.1.5810.1002/jlb.60.1.58 ↗
52. 10.1016/S0142-9612(01)00305-210.1016/S0142-9612(01)00305-2 ↗
53. 10.1177/00221554990470010710.1177/002215549904700107 ↗
54. 10.1016/S0142-9612(00)00066-110.1016/S0142-9612(00)00066-1 ↗
55. 10.1016/S1074-7613(00)80356-810.1016/S1074-7613(00)80356-8 ↗
56. Platelet membrane receptors for the complement component C1q
57. Ghebrehiwet B · 1998 · 188
58. 10.1034/j.1600-065X.2001.1800105.x10.1034/j.1600-065X.2001.1800105.x ↗
59. Platelet C1q receptor interactions with collagen‐ and C1q‐coated surfaces10.4049/jimmunol.145.9.2984 ↗
60. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation10.1016/S0021-9258(19)62004-1 ↗